Chandramouli Satish
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chandramouli Satish has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dehannathparambil Kottarathil Vijaykumar
Department of Surgical Oncology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
2 shared publications Padma Subramanyam
Department of Nuclear Medicine and PET CT, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
2 shared publications- Anupama Rajanbabu
The James Cook Cancer Institute, James Cook University Hospital, England, United Kingdom
1 shared publication Georgeena Jose
Department of Medical Research, Amrita Institute of Medical Sciences, Amrita Vishwavidyapeetham, Kochi, Kerala, India
1 shared publication- Indu Ramachandran Nair
Department of Pathology, Amrita Institute of Medical Sciences, Kochi, Kerala, India
1 shared publication P. Shanmuga Sundaram
1 shared publication
Latest Publications
- 1 September 2017
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 216, 92-97
Endometrial stromal sarcoma—A retropsective analysis of factors affecting recurrence
- 1 September 2017
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 216, 92-97
Endometrial stromal sarcoma—A retropsective analysis of factors affecting recurrence
- Open Access
- 1 January 2016
- Published by Scientific Scholar in Indian Journal of Nuclear Medicine
- Vol. 31 (1) , 9-13
Feasibility study of axillary reverse mapping lymphoscintigraphy in carcinoma breast: A concept toward preventing lymphedema
Objective: In the surgery of breast cancer, axillary reverse mapping (ARM) is the identification and preservation of arm draining lymph node (ARM node) during an axillary dissection. The assumption is that the ARM node is different from node draining breast and is unlikely to be involved even in the patients with axillary nodal metastases. If we can identify and preserve ARM node using lymphoscintigraphy; morbidity of lymphedema, as seen with axillary dissection, may be avoided. Materials and Methods: Pathologically proven 50 breast cancer patients undergoing initial surgery (cTx-4, cN0-2, and Mx-0) were included in this study. Less than 37 MBq, 0.5 ml in equally divided doses of filtered 99mTc sulfur colloid was injected intradermally into the second and third web spaces. ARM nodes in the axilla were identified with the help of Gamma Probe intraoperatively; however, their location was noted with the reference to specific anatomical landmarks and sent for histopathological examination after excision. Results: The ARM node was successfully identified in 47/50 cases (sensitivity - 94%). In 40 out of 47 cases (85%), the location of the ARM node was found to lateral to the subscapular pedicle, above the second intercostobrachial nerve and just below the axillary vein. Of the 47 patients in whom ARM node/s were identified, metastasis was noted in 5 of them (10%). Four out of these 5 patients had the pN3 disease. Conclusion: ARM node exists, and it is feasible to identify ARM node using radio isotope technique with an excellent sensitivity. ARM node seems to have a fairly constant location in more than 80% cases. It is involved with metastasis (10% cases) only when there are multiple lymph nodal metastases in the axilla.
- 1 January 2016
- Published by Scientific Scholar in Indian Journal of Nuclear Medicine
- Vol. 31 (1) , 9-13
Open AccessFeasibility study of axillary reverse mapping lymphoscintigraphy in carcinoma breast: A concept toward preventing lymphedema
Objective: In the surgery of breast cancer, axillary reverse mapping (ARM) is the identification and preservation of arm draining lymph node (ARM node) during an axillary dissection. The assumption is that the ARM node is different from node draining breast and is unlikely to be involved even in the patients with axillary nodal metastases. If we can identify and preserve ARM node using lymphoscintigraphy; morbidity of lymphedema, as seen with axillary dissection, may be avoided. Materials and Methods: Pathologically proven 50 breast cancer patients undergoing initial surgery (cTx-4, cN0-2, and Mx-0) were included in this study. Less than 37 MBq, 0.5 ml in equally divided doses of filtered 99mTc sulfur colloid was injected intradermally into the second and third web spaces. ARM nodes in the axilla were identified with the help of Gamma Probe intraoperatively; however, their location was noted with the reference to specific anatomical landmarks and sent for histopathological examination after excision. Results: The ARM node was successfully identified in 47/50 cases (sensitivity - 94%). In 40 out of 47 cases (85%), the location of the ARM node was found to lateral to the subscapular pedicle, above the second intercostobrachial nerve and just below the axillary vein. Of the 47 patients in whom ARM node/s were identified, metastasis was noted in 5 of them (10%). Four out of these 5 patients had the pN3 disease. Conclusion: ARM node exists, and it is feasible to identify ARM node using radio isotope technique with an excellent sensitivity. ARM node seems to have a fairly constant location in more than 80% cases. It is involved with metastasis (10% cases) only when there are multiple lymph nodal metastases in the axilla.
- 1 October 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (10) , e428-e430
Axillary Reverse Mapping Using 99mTc-SC
Lymphedema is a common complication in breast carcinoma patients undergoing axillary lymph node dissection. Although there is a significant reduction in the lymphedema rate with sentinel lymph node biopsy compared to axillary lymph node dissection, there is some risk after sentinel lymph node biopsy. Axillary reverse mapping, an emerging concept aims at identifying and preserving the draining lymph node of the arm that is invariably devoid of malignancy. This concept if validated may prevent lymphedema in breast carcinoma patients. Axillary reverse mapping node can be identified using a radiotracer or blue dye. We describe the procedure using filtered Tc-SC.
- 1 October 2014
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 39 (10) , e428-e430
Axillary Reverse Mapping Using 99mTc-SC
Lymphedema is a common complication in breast carcinoma patients undergoing axillary lymph node dissection. Although there is a significant reduction in the lymphedema rate with sentinel lymph node biopsy compared to axillary lymph node dissection, there is some risk after sentinel lymph node biopsy. Axillary reverse mapping, an emerging concept aims at identifying and preserving the draining lymph node of the arm that is invariably devoid of malignancy. This concept if validated may prevent lymphedema in breast carcinoma patients. Axillary reverse mapping node can be identified using a radiotracer or blue dye. We describe the procedure using filtered Tc-SC.